Author

Katsuhisa Horimoto

National Institute for Japanese Language and LinguisticsORCID 0000-0002-8328-6694Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Akihiro HiraoiD· 1 shared Harumi KagiwadaiD· 1 shared Hironori TanakaiD· 1 shared Hiroshi MiyamotoiD· 1 shared Kazuhiko FukuiiD· 1 shared Koichi OkamotoiD· 1 shared Masahiro SogabeiD· 1 shared Masashi KitazawaiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Akihiro HiraoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Molecular BiologybioRxivPreprintJan 3, 2020

Therapeutic Efficacy and Safety of Lenvatinib for Unresectable Hepatocellular Carcinoma Beyond Progression with Sorafenib

Tetsu Tomonari, Yasushi Sato, Hironori Tanaka…·Tetsuji Takayama

This study evaluates lenvatinib's efficacy and safety as second/third-line treatment for unresectable HCC after sorafenib, showing higher response rates and survival in earlier lines and better liver function.

DOI 10.1101/2020.01.03.893800

humanproteomics

𝕏 PostBluesky